Dose Dense Abraxane in Adjuvant Chemotherapy for Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Abraxane
Sponsor: Harold J. Burstein, MD, PhD
Collaborators: Celgene Corporation|Beth Israel Deaconess Medical Center|Massachusetts General Hospital